ANXA2 and pancreatic neoplasm: Our current findings suggest that SNHG14 potentiates pancreatic cancer progression through modulation of annexin A2 expression via acting as a competing endogenous RNA for miR‐613, and that the SNHG14‐miR‐613‐ANXA2 axis may represent a key signalling pathway for pancreatic cancer progression.